Baseline mucosal transcriptomic endotypes stratify healing capacity and biologic therapy outcomes in ulcerative colitis: an integrative multi-cohort study.

Chen W, Zeng S

Open source

DOI
10.3389/fphar.2026.1931118
Published
2026
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1931118,
  title = {Baseline mucosal transcriptomic endotypes stratify healing capacity and biologic therapy outcomes in ulcerative colitis: an integrative multi-cohort study.},
  author = {Chen W and Zeng S},
  year = {2026},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2026.1931118},
  url = {https://doi.org/10.3389/fphar.2026.1931118}
}

RIS

TY  - JOUR
TI  - Baseline mucosal transcriptomic endotypes stratify healing capacity and biologic therapy outcomes in ulcerative colitis: an integrative multi-cohort study.
AU  - Chen W
AU  - Zeng S
PY  - 2026
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2026.1931118
UR  - https://doi.org/10.3389/fphar.2026.1931118
ER  - 

APA

W, C., & S, Z. (2026). Baseline mucosal transcriptomic endotypes stratify healing capacity and biologic therapy outcomes in ulcerative colitis: an integrative multi-cohort study.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1931118

Source records